Identification of low molecular weight degradation merchandise from chitin and chitosan by electrospray ionization time-of-flight mass spectrometry
The useful results offered by chitosan oligosaccharides (COS) make them of curiosity in medical analysis. The monomers that represent COS confer distinct properties, so controlling COS composition throughout their manufacturing is critical.
On this work, we degraded chitin and chitosan polymers and recognized low molecular weight merchandise reminiscent of COS that fashioned, utilizing electrospray ionization time-of-flight mass spectrometry.
Our outcomes present that hydrochloric acid, hydrogen peroxide, and nitrous acid generate distinct merchandise from chitin and chitosan.
Hydrochloric acid degrades chitin and chitosan to supply glucosamine (GlcN) monomers and oligomers. Hydrogen peroxide degrades chitosan to supply GlcN and N-acetyl-d-glucosamine (GlcNAc) monomers and oligomers, and nitrous acid degrades chitosan to supply 2,5-anhydro- d-mannose.
Our research present that COS composition is dictated by each the degradation protocol and the beginning polymer. Moreover, our outcomes allow number of degradation protocols primarily based on their capability to degrade chitin and chitosan and facilitate the manufacturing of COS with desired compositions.
Key phrases: Chitin; Chitosan; Mass spectrometry; Polysaccharide degradation.
allelebio
PSMB8 Antibody |
|||
| 43134 | SAB | 100ul | EUR 319 |
PSMB8 Antibody |
|||
| 43134-100ul | SAB | 100ul | EUR 302.4 |
PSMB8 Antibody |
|||
| 1-CSB-PA018886GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA116429 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA775839 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| E043134 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| BF0434 | Affbiotech | 200ul | EUR 540 |
PSMB8 Antibody |
|||
| BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| E94054 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E314816 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E97340 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
| MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
| MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 antibody |
|||
| MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
| MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
| MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
| MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Polyclonal Antibody |
|||
| A73468 | EpiGentek |
|
|
PSMB8 Conjugated Antibody |
|||
| C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 polyclonal antibody |
|||
| BS91127 | Bioworld Biotech | 50ul | EUR 398 |
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
PSMB8 polyclonal antibody |
|||
| BS78214 | Bioworld Biotech | 50ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
PSMB8 polyclonal antibody |
|||
| BS8845 | Bioworld Biotech | 50 ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 monoclonal antibody |
|||
| MB66639 | Bioworld Biotech | 50ul | EUR 275 |
|
Description: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3. |
|||
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
| RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Antibody (N-term) |
|||
| MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
| 1-CSB-PA018886LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
| 1-CSB-PA018886LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, FITC Conjugated |
|||
| MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |
Molecular docking and dynamics simulations research of OmpATb identifies 4 potential novel pure product-derived anti-Mycobacterium tuberculosis compounds
The outer membrane protein A (OmpATb) of Mycobacterium tuberculosis is a virulence issue that neutralizes the host pH to impede the uptake of hydrophilic antitubercular medication. Figuring out pure compounds with the potential to inhibit OmpATb might enable circumvention of the porin-like actions of OmpATb. 4 potential leads comprising ZINC000003958185, ZINC000000157405, ZINC000000001392 and ZINC000034268676 had been obtained by digital screening of 6394 numerous pure merchandise.
Characterization of the binding interactions of the potential leads with OmpATb revealed 9 crucial residues comprising ARG86, LEU110, LEU113, LEU114, ALA115, PHE142, SER145, VAL146, and PHE151. Molecular dynamics simulations additionally revealed very steady protein-lead complexes. Most residues contributed decrease binding energies to the general molecular mechanics Poisson-Boltzmann floor space (MM-PBSA) binding free energies of the interactions between the molecules and OmpATb protein.
Induced Match Docking (IFD) of the compounds regenerated poses of the molecular docking utilizing AutoDock Vina. These molecules might be beginning templates for designing inhibitors to bypass the pore mediating actions of OmpATb. Based mostly on structural similarity, ZINC000034268676 was urged as a possible scaffold for designing efflux pump inhibitors of the gate mediating actions of OmpATb and will improve the uptake of hydrophilic medication to cut back the period time of tuberculosis therapy.
Moreover, structurally comparable compounds out there within the DrugBank database with a similarity threshold of 0.7 have been reported to exhibit antitubercular and anti-mycobacterial actions. These biomolecules might be additional characterised experimentally to corroborate their antitubercular exercise. Additionally, the skeletons of the molecules might be adopted as sub-structures for the design of future anti-mycobacterial medication.
Key phrases: Antitubercular compounds; Induced-fit docking; MM-PBSA; Molecular docking; Molecular dynamics; Mycobacterium tuberculosis OmpATb; Pure merchandise; Digital screening
Placing the Brakes on Tumorigenesis with Pure Merchandise of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Most cancers Remedy.
Bladder most cancers is the 10th mostly identified most cancers worldwide. Though the incidence in males is four instances larger than that in ladies, the diagnoses are worse for ladies.
Over the previous 30 years, the therapy for bladder most cancers has not achieved a major optimistic impact, and the outlook for mortality charges resulting from muscle-invasive bladder most cancers and metastatic illness isn’t optimistic. Phytochemicals present in crops and their derivatives current promising potentialities for most cancers remedy with improved therapy results and decreased toxicity.
On this examine, we summarize the promising pure merchandise of plant origin with anti-bladder most cancers potential, and their anticancer mechanisms-especially apoptotic induction-are mentioned.
With the developments in immunotherapy, small-molecule focused immunotherapy has been promoted as a passable strategy, and the invention of novel small molecules towards immune targets for bladder most cancers therapy from merchandise of plant origin represents a promising avenue of analysis. It’s our hope that this might pave the way in which for brand spanking new concepts within the fields of oncology, immunology, phytochemistry, and cell biology, using pure merchandise of plant origin as promising medication for bladder most cancers therapy
PSMB8 Antibody |
|||
| 43134 | SAB | 100ul | EUR 319 |
PSMB8 Antibody |
|||
| 43134-100ul | SAB | 100ul | EUR 302.4 |
PSMB8 Antibody |
|||
| 1-CSB-PA018886GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA116429 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA775839 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| E043134 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| BF0434 | Affbiotech | 200ul | EUR 540 |
PSMB8 Antibody |
|||
| BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| E94054 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E314816 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E97340 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
| MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
| MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 antibody |
|||
| MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
| MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
| MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
| MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Polyclonal Antibody |
|||
| A73468 | EpiGentek |
|
|
PSMB8 Conjugated Antibody |
|||
| C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 polyclonal antibody |
|||
| BS91127 | Bioworld Biotech | 50ul | EUR 398 |
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
PSMB8 polyclonal antibody |
|||
| BS78214 | Bioworld Biotech | 50ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
PSMB8 polyclonal antibody |
|||
| BS8845 | Bioworld Biotech | 50 ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 monoclonal antibody |
|||
| MB66639 | Bioworld Biotech | 50ul | EUR 275 |
|
Description: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3. |
|||
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
| RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Antibody (N-term) |
|||
| MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
| 1-CSB-PA018886LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
| 1-CSB-PA018886LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, FITC Conjugated |
|||
| MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |